Randomised clinical endpoint studies for trastuzumab biosimilars: a systematic review

Overview of attention for article published in Breast Cancer Research and Treatment, April 2019

Altmetric Badge

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 2 Dimensions

Readers on

mendeley: 29 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 18,370 followers.

RT @AnnemarieVtW: Randomised clinical endpoint studies for #trastuzumab #biosimilars: a systematic review | SpringerLink https://t.co/hZFPc…

Reply Repost Favourite

RT @AnnemarieVtW: Randomised clinical endpoint studies for #trastuzumab #biosimilars: a systematic review | SpringerLink https://t.co/hZFPc…

Reply Repost Favourite